■ Market Review

On Oct. 24, CTC BIO (060590) increased 1.75% to 9,860 won (US$8.70). It had declined 12.36% through the past month. Standard deviation, which indicates variableness, records 2% over the same period of time over one month.

Compared with its close competitors within the same industry, KOSDAQ, since the monthly volatility of CTC BIO was at a low level, the earnings rate over one month was also relatively lower than that of its peer group. Over the recent month, the return-on-risk, the return on investment with consideration about risk, was -6.1%. By tumbling of stock price, return-on-risk is the lowest among its peer group in spite of low volatility. Moreover, compared with the KOSDAQ industry, the return-on-risk is below the industrial mean, -6.0, and thus the industrial comparison performance was not so good.

Close Competitors Earning rate (%) STD (1Mo) Return on Risk (1Mo)
1 Mo 3 Mo 6 Mo
A-motion(031860) 13.9% 8.2% 2.4% 4.3% 3.2
IE(023430) -20.1% 20.1% 108.8% 4.0% -5.0
MPK(065150) 5.8% -8.2% -12.8% 2.1% 2.7
CTC BIO(060590) -12.4% -33.8% -37.6% 2.0% -6.1
SAMT(031330) -3.3% 5.0% -11.1% 1.9% -1.7
Distribution -5.6% -6.7% -8.8% 0.8% -7.0
KOSDAQ -4.8% -6.3% -7.5% 0.9% -6.0

■ Earnings & Valuation

CTC BIO(060590): 2Q(Apr ~ June) of 2016 Earnings (reported at Aug. 17. 2016)
Revenue Operating Income Net Income
2Q of 2016 296.6 T -5.5 T -0.7 T
Previous Quarter 5.6% increase turn to a loss turn to a loss
YoY 5.3% increase turn to a loss turn to a loss

Financial structure Overview

Compared with 4 close competitors with similar market capitalization within its industry, CTC BIO's P/B ratio, a financial ratio of a company's book value, and its P/E ratio, a price-paid ratio of annual net income, are both at a relatively lower level.

P/E ratio and P/B ratio

Close Compatitors ROE PER PBR Basic Date
CTC BIO(060590) 0.7 265.9 1.8 June 2016
IE(023430) 0.0 - - June 2016
A-motion(031860) -29.8 - 4.3 June 2016
SAMT(031330) 24.8 6.1 1.5 June 2016
MPK(065150) 0.4 965.2 4.0 June 2016

■ Investor Group

Institutions and Foreigners sell, Individuals buy From Oct. 17, institutions have been continously selling CTC BIO during the past five trading days. As a shareholding sum by investor group for the past four weeks, foreigners have sold 16,731 shares and institutions have sold 199,129 shares with a selling trend. However, during the same period, individuals have bought 215,860 shares with an increasing position.

Cumulated shareholdings per investor group (1Mo) Total shareholdings per investor group

* Other Investor groups, included as "other corporations", are considered as "Individuals".

By HeRo ()This article is produced by the algorithm developed by the artificial intelligence developer ThinkPool in collaboration with Herald Corp.